Palladyne AI Corp. (NASDAQ: PDYN) witnessed a significant rise in its stock value this morning, following the announcement of a critical defense contract. As of the latest trading update, the company’s shares soared by 13.14%, reaching $8.25. Air Force Contract Propels Innovation Palladyne (PDYN) revealed that it secured a new contract from the Air Force …
Defense Contract Fuels Palladyne (PDYN) Stock Surge Read More »
Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) have been sharply rising on the charts following the release of encouraging clinical trial results. Its stock price has grown an astounding 130.18% to $3.89 per share as of the most recent pre-market check. PHIO Shared Clinical Studies Showing Favorable Results Phio Pharmaceuticals, a clinical-stage biotechnology business, is …
Pre-Market Surge For Phio Pharmaceuticals Following Clinical Success Read More »
Shares of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) are rising on the US stock charts today in response to the takeover move. As of the latest pre-market check, ITCI stock was trading up 34.45% to $127.55. Expansion of Neuroscience Strategically Intra-Cellular Therapies (ITCI) and Johnson & Johnson (JNJ) announced their purchase deal. Under the terms of …
Pre-Hour Stock Surge: Intra-Cellular (ITCI) Rises On Acquisition Agreement Read More »
The shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) increased significantly after the firm acknowledged receiving a non-binding buyout proposal from Biogen Inc. Following the news, SAGE’s stock price jumped 46.11% in after-hours trading, reaching $8.11 per share. The Proposal and Strategic Offer of Biogen An unsolicited proposal has been made by Biogen, which already owns …
Sage Therapeutics Sees After-Hours Stock Boost After Acquisition Offer Read More »
Shares of Traws Pharma, Inc. (NASDAQ: TRAW) experienced a significant surge last Friday, rising by 57.57% during after-hours trading to reach $12.70. The dramatic spike came after the business made a ground-breaking disclosure on its H5N1 antiviral program, highlighting the promise of its experimental medication, Tivoxavir Marboxil. Promising Results from a Novel Antiviral Drug A …
Traws Pharma (TRAW) Stock Skyrockets In After-Hour Trading Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.